Jamal Musiala has suffered another health setback, renewing concern at Bayern Munich as internal discussions over his situation and future intensify following controversial comments from several club officials.
According to Bild, the Germany international experienced a brief absence seizure last Monday, his second such episode since collapsing during the friendly against Heidenheim in August.
The latest episode occurred on the same day Bayern’s supervisory board met that evening to discuss how to handle the player’s situation following recent developments, heightening the management’s concerns.
Doctors adjusted Musiala’s medication after the Heidenheim match, but a subsequent episode prompted another adjustment. The recurrence on Monday means finding the most suitable treatment remains an ongoing challenge.
Both episodes occurred within the past 12 weeks. His medication is now being adjusted again, with his representatives remaining in regular contact with Bayern over his health.
According to the report, these developments explain the growing concern among the club’s leadership and the public comments made first by Uli Hoeneß, then chief executive Jan-Christian Dreesen and subsequently Karl-Heinz Rummenigge about Musiala’s situation and prospects of regaining his previous form.
The handling of the matter has drawn widespread criticism, particularly after his health was discussed in relation to the value of his contract. Club president Herbert Hainer, however, reaffirmed Bayern’s backing: “Jamal is receiving all the support and all the time he needs from the club.”
Musiala disclosed in August that he had a neurological disorder causing brief absence seizures, after collapsing during two consecutive friendlies. Managing his condition has since required ongoing coordination between the player, his doctors and the club.
The 23-year-old returned from a muscle injury to play around 20 minutes against Cologne on Friday in a match that finished 1–1. His Bayern contract runs until the summer of 2030.




